$1.62-0.01 (-0.61%)
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada.
AirSculpt Technologies, Inc. in the Healthcare sector is trading at $1.62 with a market capitalization of $128M. Wall Street consensus targets $4.50 (2 analysts), implying a +177.8% move over the next 12 months. The stock is currently near its 52-week low of $1.51, remaining 48.9% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $42.90Mβ | $39.39Mβ | $33.44Mβ | $34.99Mβ | $44.01M |
| Gross Profit | $26.33Mβ | $23.80Mβ | $19.77Mβ | $20.13Mβ | $26.81M |
| Operating Income | -$29,000β | -$1.80Mβ | -$1.52Mβ | -$2.61Mβ | $894,000 |
| Net Income | -$1.11Mβ | -$2.40Mβ | $1.28Mβ | -$9.51Mβ | -$591,000 |
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a ...